Caroline Bradford

FDA Leaders Moving to Abandon Advisory Committee Reviews of Specific New Drugs

STAT News, September 12, 2025: FDA seeks to abandon Advisory Committees for specific drugs and use them for bigger issues says CDER head George Tidmarsh. We point out that Expert Panels are also replacing Advisory Committees with one-sided reviews.

The Business of Pet Adoption

The Times-Journal (Alabama), September 5, 2025: Pets play a leading role in many people’s lives. Researchers tell us that companion animals (pets) improve human health and well-being. For example, pets can help lower blood pressure, improve heart health, have fewer sick days, and get more exercise.

Taking Medication While Pregnant or Breastfeeding

If you are pregnant or breastfeeding and are planning to take a medication or get a vaccine, it is important to learn more about the possible risks and to discuss any potential side effects with your healthcare provider. It is also important to understand that your doctor may not know exactly what the risks are of certain prescription and over-the-counter medications. Some risks associated with medications have not been researched yet or might not be known by most doctors.

Testimony of Dr. Diana Zuckerman at the FDA Plastic Surgery Advisory Panel Meeting On Dermal Fillers for the Decolletage Area

August 13, 2025: Diana Zuckerman testified at the FDA panel meeting about the risks of dermal filler for decolletage. Known risks include pain, lumps, rashes, stroke, and interference with breast cancer screening. We explained that patients and their physicians need specific information about the frequency of these risks so that they can make informed decisions about whether they want this cosmetic procedure.

NCHR Public Comment on the Continued Implementation of the National Youth Tobacco Survey

In our public comment to the CDC, we strongly supported the continued operation of the National Youth Tobacco Survey (NYTS) for the 2026-2028 cycle. NYTS is the cornerstone of public health surveillance in this field and we reminded CDC and FDA that evaluating the youth use of tobacco products is an essential tool of U.S. public health strategies to reduce cancer, heart disease, and chronic diseases that are key to the MAHA movement.